Various investment entities have picked up more shares in
Kimberly-Clark Co, indicating a growing confidence in the company's stock. As of Q1 2025, there were increases in holdings by Edgestream Partners and various others. However, questions linger about Kimberly-Clark's ability to sustain its dividends in the face of mounting market uncertainty. CNBC's Jim Cramer also points out that the company has an 'Amazon problem'. On a brighter note, Piper Sandler upgraded the company's rating to Overweight with a price target of $144. A significant part of this positive outlook could be the company's announcement of a major stride forward in its
Powering Care Transformation. Various investor sentiments accompanied an announcement about Kimberly-Clark shifting its U.S. Stock Exchange listing to Nasdaq. As for its Q1 2025 performance, it was noted for strategic innovations and margin. There were, however, sales below analyst estimates. The company further plans to invest $2 Billion to expand US manufacturing, accelerate innovation, and fuel growth. Finally, Kimberly-Clark, in partnership with Suzano, plans to form a global tissue company.
Kimberly-Clark Corp KMB News Analytics from Fri, 13 Sep 2024 07:00:00 GMT to Sat, 19 Jul 2025 20:22:31 GMT -
Rating 2
- Innovation -1
- Information 6
- Rumor -4
